Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers

FierceBiotechAdaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business

PharmaVoiceHow Lilly is defending its GLP empire

Promega BlogThe Hidden Costs of “Good Enough” Extraction

Clinical OMICsAdaptive Deep Brain Stimulation Improves Walking and Reduces Falls in Parkinson’s Disease

FierceBiotechHow Biogen is transforming its pipeline with a VC mindset and an ‘entrepreneurial spirit’

BioWorldAppointments and advancements for June 16, 2026

BioWorldIn the clinic for June 16, 2026

BioWorldOther news to note for June 16, 2026

BioWorldRegulatory actions for June 16, 2026

BioPharma Dive[Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus

Endpoints NewsUCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancer

IlluminaIllumina Ventures Announces NAX Bioscience as a Winner of Inaugural Irish Genomics Business Plan Competition - University College Dublin